Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K G Warren

Showing results (41-50 of 79) with videos related to

Pageof 8
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 25, 2008
Contribution of incidence to increasing prevalence of multiple sclerosis in Alberta, CanadaS A Warren, L W Svenson, K G Warren
Neuroepidemiology|January 1, 1996
Parental ancestry and risk of multiple sclerosis in Alberta, CanadaS Warren, L Svenson, S Woodhead, et al.
Canadian Medical Association Journal|February 15, 1982
How multiple sclerosis is related to animal illness, stress and diabetesS A Warren, K G Warren, S Greenhill, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 1, 1984
Evidence for cardiovascular autonomic nerve dysfunction in multiple sclerosisM P Senaratne, D Carroll, K G Warren, et al.
The Journal of General Virology|December 1, 1983
Variable restriction endonuclease sites of herpes simplex virus type 1 isolates from encephalitic, facial and genital lesions and gangliaS M Chaney, K G Warren, J H Subak-Sharpe
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|February 1, 1986
Effect of methylprednisolone on CSF IgG parameters, myelin basic protein and anti-myelin basic protein in multiple sclerosis exacerbationsK G Warren, I Catz, V M Jeffrey, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|August 1, 1976
Computer tomography in disseminated sclerosisK G Warren, M J Ball, D W Paty, et al.
European Journal of Neurology|August 2, 2006
Intravenous synthetic peptide MBP8298 delayed disease progression in an HLA Class II-defined cohort of patients with progressive multiple sclerosis: results of a 24-month double-blind placebo-controlled clinical trial and 5 years of follow-up treatmentK G Warren, I Catz, L Z Ferenczi, et al.
Antimicrobial Agents and Chemotherapy|March 1, 1983
Effects of prolonged cultivation in the presence of acyclovir on recovery of latent herpes simplex virus from human trigeminal gangliaM E Lewis, K G Warren, V M Jeffrey, et al.
Lancet (London, England)|May 29, 1976
Letter: Herpes labialis and multiple sclerosisK G Warren, D W Paty, S A McFarlane, et al.
Pageof 8

Showing results (41-50 of 79) with videos related to

Sort By:
Pageof 8
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 25, 2008
Contribution of incidence to increasing prevalence of multiple sclerosis in Alberta, CanadaS A Warren, L W Svenson, K G Warren
Neuroepidemiology|January 1, 1996
Parental ancestry and risk of multiple sclerosis in Alberta, CanadaS Warren, L Svenson, S Woodhead, et al.
Canadian Medical Association Journal|February 15, 1982
How multiple sclerosis is related to animal illness, stress and diabetesS A Warren, K G Warren, S Greenhill, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 1, 1984
Evidence for cardiovascular autonomic nerve dysfunction in multiple sclerosisM P Senaratne, D Carroll, K G Warren, et al.
The Journal of General Virology|December 1, 1983
Variable restriction endonuclease sites of herpes simplex virus type 1 isolates from encephalitic, facial and genital lesions and gangliaS M Chaney, K G Warren, J H Subak-Sharpe
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|February 1, 1986
Effect of methylprednisolone on CSF IgG parameters, myelin basic protein and anti-myelin basic protein in multiple sclerosis exacerbationsK G Warren, I Catz, V M Jeffrey, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|August 1, 1976
Computer tomography in disseminated sclerosisK G Warren, M J Ball, D W Paty, et al.
European Journal of Neurology|August 2, 2006
Intravenous synthetic peptide MBP8298 delayed disease progression in an HLA Class II-defined cohort of patients with progressive multiple sclerosis: results of a 24-month double-blind placebo-controlled clinical trial and 5 years of follow-up treatmentK G Warren, I Catz, L Z Ferenczi, et al.
Antimicrobial Agents and Chemotherapy|March 1, 1983
Effects of prolonged cultivation in the presence of acyclovir on recovery of latent herpes simplex virus from human trigeminal gangliaM E Lewis, K G Warren, V M Jeffrey, et al.
Lancet (London, England)|May 29, 1976
Letter: Herpes labialis and multiple sclerosisK G Warren, D W Paty, S A McFarlane, et al.
Pageof 8